• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Endeavor Group Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket

    10/26/23 8:53:37 AM ET
    $AKLI
    $ALGN
    $BHAT
    $BMRA
    Medical/Dental Instruments
    Health Care
    Industrial Specialties
    Health Care
    Get the next $AKLI alert in real time by email

    Gainers

    • Appreciate Holdings, Inc. (NASDAQ:SFR) shares surged 103.8% to $0.2460 in pre-market trading after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding delisting.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) shares gained 56.5% to $0.7174 in pre-market trading after falling 21% on Wednesday. NextPlay Technologies received a notice from Nasdaq regarding a delayed second-quarter report.
    • IM Cannabis Corp. (NASDAQ:IMCC) shares climbed 48.1% to $0.31 in pre-market trading.
    • Jaguar Global Growth Corporation I (NASDAQ:JGGC) shares rose 23.4% to $8.12 in pre-market trading after gaining over 18% on Wednesday.
    • Endeavor Group Holdings, Inc. (NYSE:EDR) rose 22.7% to $21.74 in pre-market trading after the company announced a review of strategic alternatives.
    • Nxu, Inc. (NASDAQ:NXU) shares rose 15.9% to $0.0415 in pre-market trading. Nxu recently reported the closing of a $3.0 million public offering of common stock.
    • Mangoceuticals, Inc. (NASDAQ:MGRX) shares jumped 15.5% to $0.8665 in pre-market trading after falling around 14% on Wednesday. Mangoceuticals recently announced the official launch of the MangoRx affiliate marketing program to enhance and accelerate topline growth.
    • Green Giant Inc. (NASDAQ:GGE) rose 14.8% to $0.7690 in pre-market trading after dipping 14% on Wednesday.
    • NeuBase Therapeutics, Inc. (NASDAQ:NBSE) gained 14.3% to $0.7661 in pre-market trading.
    • JOANN Inc. (NASDAQ:JOAN) shares rose 14.1% to $0.7670 in pre-market trading.

    Losers

    • Align Technology, Inc. (NASDAQ:ALGN) dipped 25.3% to $189.50 in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued guidance.
    • Biomerica, Inc. (NASDAQ:BMRA) shares fell 21.5% to $0.70 in pre-market trading after gaining 6% on Wednesday. Biomerica recently posted a narrower loss for the first quarter.
    • MaxLinear, Inc. (NASDAQ:MXL) fell 21.2% to $14.50 in pre-market trading after reporting downbeat results for the third quarter. Roth MKM downgraded MaxLinear from Buy to Neutral and lowered the price target from $35 to $18.
    • Theratechnologies Inc. (NASDAQ:THTX) shares fell 21.1% to $1.01 in pre-market trading as the company reported a proposed public offering of common shares and concurrent private placement.
    • Akili, Inc. (NASDAQ:AKLI) shares fell 18.5% to $0.40 in pre-market trading. Akili is expected to report its financial and operating results for the third quarter on Nov. 9, 2023.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) shares fell 14.3% to $2.33 in pre-market trading after jumping over 33% on Wednesday. Fujian Blue Hat Interactive Entertainment Technology recently filed for a mixed shelf of up to $150 million.
    • WANG & LEE GROUP, Inc. (NASDAQ:WLGS) fell 13.7% to $0.54 in pre-market. WANG & LEE GROUP received written notification from the Nasdaq that it no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market according to the Nasdaq Listing Rule 5550(a)(2).
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) shares fell 12.5% to $1.12 in pre-market trading after gaining over 5% on Wednesday.
    • Mattel, Inc. (NASDAQ:MAT) shares fell 10.2% to $18.05 in pre-market trading after reporting third-quarter results.
    • Meta Platforms, Inc. (NASDAQ:META) fell 3.3% to $289.65 in pre-market trading. Meta reported better-than-expected results for its third quarter. The company said it sees fourth-quarter revenue coming in a range of $36.5 billion to $40 billion.

     

    Now Read This: Fear Continues To Grip Markets As S&P 500 Settles Below 4,200

    Get the next $AKLI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKLI
    $ALGN
    $BHAT
    $BMRA

    CompanyDatePrice TargetRatingAnalyst
    Align Technology Inc.
    $ALGN
    3/17/2026$200.00Equal Weight → Overweight
    Barclays
    Mattel Inc.
    $MAT
    3/11/2026$19.00Overweight
    Wells Fargo
    Meta Platforms Inc.
    $META
    3/5/2026Buy → Neutral
    Arete
    Meta Platforms Inc.
    $META
    3/5/2026Hold → Buy
    Erste Group
    Meta Platforms Inc.
    $META
    2/23/2026$849.00 → $856.00Overweight
    Wells Fargo
    Mattel Inc.
    $MAT
    2/11/2026$14.00Neutral → Underweight
    Analyst
    Mattel Inc.
    $MAT
    2/11/2026$16.00Buy → Neutral
    Citigroup
    Align Technology Inc.
    $ALGN
    2/9/2026$200.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $AKLI
    $ALGN
    $BHAT
    $BMRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Align Tech upgraded by Barclays with a new price target

    Barclays upgraded Align Tech from Equal Weight to Overweight and set a new price target of $200.00

    3/17/26 7:53:01 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Wells Fargo initiated coverage on Mattel with a new price target

    Wells Fargo initiated coverage of Mattel with a rating of Overweight and set a new price target of $19.00

    3/11/26 8:38:58 AM ET
    $MAT
    Recreational Games/Products/Toys
    Consumer Discretionary

    Meta Platforms downgraded by Arete

    Arete downgraded Meta Platforms from Buy to Neutral

    3/5/26 8:27:42 AM ET
    $META
    Computer Software: Programming Data Processing
    Technology

    $AKLI
    $ALGN
    $BHAT
    $BMRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Kreiz Ynon bought $1,009,300 worth of shares (65,000 units at $15.53), increasing direct ownership by 4% to 1,794,217 units (SEC Form 4)

    4 - MATTEL INC /DE/ (0000063276) (Issuer)

    2/12/26 3:39:47 PM ET
    $MAT
    Recreational Games/Products/Toys
    Consumer Discretionary

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $AKLI
    $ALGN
    $BHAT
    $BMRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cohen Jacob D.

    4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)

    3/20/26 5:00:28 PM ET
    $MGRX
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Cohen Jacob D.

    4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)

    3/20/26 5:00:40 PM ET
    $MGRX
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Kimmitt Robert M

    4 - Meta Platforms, Inc. (0001326801) (Issuer)

    3/18/26 6:14:31 PM ET
    $META
    Computer Software: Programming Data Processing
    Technology

    $AKLI
    $ALGN
    $BHAT
    $BMRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results

    PURCHASE, N.Y., March 23, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders, (the "Company" or "Cognition"), plans to release financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, March 26, 2026 before the market open. Management will host a conference call at 8:30 a.m. ET on the same day to review the financial and operating results and provide a business update.    Conference Call InformationTo participate in the conference call, dial (800) 445-7795 (U.S.) or (785) 424-1699 (international) and provide conference ID number CGTXQ4. The webc

    3/23/26 7:30:00 AM ET
    $CGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles

    NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- MiningNewsWire Editorial Coverage: Rare earth metallization sits deep in the industrial stack, but it is one of the steps that determines whether advanced manufacturing can actually function at scale. China's dominance over rare earth refining, metallization and magnet production has left automakers, electronics manufacturers, robotics developers, defense contractors and data-center-adjacent industrial supply chains exposed to a single concentrated source. That exposure helps explain why companies such as REalloys (NASDAQ:ALOY) (MNW Profile News) are drawing attention – The company is working to rebuild a North American mine-to-magnet platform t

    3/18/26 9:00:00 AM ET
    $ALOY
    $AMD
    $IBM
    Semiconductors
    Technology
    Computer Manufacturing
    Computer Software: Programming Data Processing

    Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe

    First Commercial Order by Large Lab Chain: Biomerica has received its first commercial order for Hp Detect™, from one of the largest clinical laboratory chains operating across Europe.Strategic Account: This new lab's scale and geographic reach across Europe positions it as a reference account and potential gateway to broader EU laboratory channel adoption.Repeat Order Potential: Based on the nature of the relationship, Biomerica believes this initial order will result in recurring orders as Hp Detect™ is integrated into the customer's routine testing workflow.Disease Burden: H. pylori affects an estimated 45% of the population across Europe's five largest countries. The WHO designates H. py

    3/18/26 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $AKLI
    $ALGN
    $BHAT
    $BMRA
    SEC Filings

    View All

    SEC Form 6-K filed by IM Cannabis Corp.

    6-K - IM Cannabis Corp. (0001792030) (Filer)

    3/17/26 4:03:41 PM ET
    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care

    Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MANGOCEUTICALS, INC. (0001938046) (Filer)

    3/17/26 4:00:33 PM ET
    $MGRX
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 144 filed by Meta Platforms Inc.

    144 - Meta Platforms, Inc. (0001326801) (Subject)

    3/16/26 4:07:59 PM ET
    $META
    Computer Software: Programming Data Processing
    Technology

    $AKLI
    $ALGN
    $BHAT
    $BMRA
    Leadership Updates

    Live Leadership Updates

    View All

    Barbie Celebrates International Women's Day With First-ever Barbie Dream Team of Global Female Role Models

    Celebratory month to also feature Barbie Dream Days programming and the debut of Barbie Dream Fest multi-day fan experience. Mattel, Inc. (NASDAQ:MAT) announced today that Barbie® is marking International Women's Day with a month-long celebration, including the launch of its first-ever Barbie™ Dream Team honoring women who led the way in their industries with one-of-a-kind dolls made in their likeness, special Barbie Dream Days™ programming, and the debut of Barbie Dream Fest, a multi-day fan experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304952754/en/BARBIE CELEBRATES INTERNATIONAL WOMEN'S DAY WITH FIRST-EVER B

    3/5/26 12:00:00 AM ET
    $MAT
    Recreational Games/Products/Toys
    Consumer Discretionary

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors

    TORONTO and GLIL YAM, Israel, Jan. 5, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), medical cannabis company with operations in Israel and Germany, announced today that Mr. Alon Dayan has been appointed to the Company's board of directors effective December 31, 2025. Mr. Dayan, who is currently the Chief Executive Officer of KeepZone AI Inc., a position he has held since 2025, brings over 15 years of executive experience in the homeland security technology sector, with a proven track record of founding and scaling innovative companies focused on systems integration, secure communications, and international business development. As the founder and Chief Execu

    1/5/26 8:55:00 AM ET
    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKLI
    $ALGN
    $BHAT
    $BMRA
    Financials

    Live finance-specific insights

    View All

    Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results

    PURCHASE, N.Y., March 23, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders, (the "Company" or "Cognition"), plans to release financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, March 26, 2026 before the market open. Management will host a conference call at 8:30 a.m. ET on the same day to review the financial and operating results and provide a business update.    Conference Call InformationTo participate in the conference call, dial (800) 445-7795 (U.S.) or (785) 424-1699 (international) and provide conference ID number CGTXQ4. The webc

    3/23/26 7:30:00 AM ET
    $CGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Meta Announces Quarterly Cash Dividend

    MENLO PARK, Calif., Feb. 12, 2026 /PRNewswire/ -- The Meta Platforms, Inc. (NASDAQ:META) board of directors today declared a quarterly cash dividend of $0.525 per share of the company's outstanding Class A common stock and Class B common stock, payable on March 26, 2026 to stockholders of record as of the close of business on March 16, 2026. About MetaMeta is building the future of human connection, powered by artificial intelligence and immersive technologies. When Facebook launched in 2004, it changed the way people connect. Apps like Messenger, Instagram, and WhatsApp furth

    2/12/26 4:05:00 PM ET
    $META
    Computer Software: Programming Data Processing
    Technology

    Mattel Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Highlights Versus Prior Year Net Sales of $1,766 million, up 7% as reported, and 5% in constant currency Gross Margin of 45.9%, a decrease of 480 basis points; Adjusted Gross Margin of 46.0%, a decrease of 480 basis points Operating Income of $141 million, a decrease of $17 million; Adjusted Operating Income of $160 million, a decrease of $1 million Net Income of $106 million, a decrease of $35 million Earnings per Share of $0.34 compared to $0.42 per share; Adjusted Earnings per Share of $0.39 compared to $0.35 per share Full Year 2025 Highlights Versus Prior Year Net Sales of $5,348 million, down 1% as reported and in constant currency Gross Mar

    2/10/26 4:10:00 PM ET
    $MAT
    Recreational Games/Products/Toys
    Consumer Discretionary

    $AKLI
    $ALGN
    $BHAT
    $BMRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mattel Inc.

    SC 13G/A - MATTEL INC /DE/ (0000063276) (Subject)

    11/14/24 4:26:57 PM ET
    $MAT
    Recreational Games/Products/Toys
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Biomerica Inc.

    SC 13G/A - BIOMERICA INC (0000073290) (Subject)

    11/14/24 4:19:51 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by Endeavor Group Holdings Inc.

    SC 13G/A - Endeavor Group Holdings, Inc. (0001766363) (Subject)

    11/14/24 12:09:58 PM ET
    $EDR
    Services-Misc. Amusement & Recreation
    Consumer Discretionary